In the present study, we provided proof for the specific role of OPTN in the clearance of hyperphosphorylation Tau protein, which may provide a possible avenue in the treatment of Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.